0001723292-19-000001.txt : 20190405 0001723292-19-000001.hdr.sgml : 20190405 20190404184755 ACCESSION NUMBER: 0001723292-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190405 DATE AS OF CHANGE: 20190404 EFFECTIVENESS DATE: 20190405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cleo Labs, Inc CENTRAL INDEX KEY: 0001723292 IRS NUMBER: 811067638 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-336534 FILM NUMBER: 19733203 BUSINESS ADDRESS: STREET 1: 399 WEBSTER STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94117 BUSINESS PHONE: (415) 935-1009 MAIL ADDRESS: STREET 1: 399 WEBSTER STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94117 FORMER COMPANY: FORMER CONFORMED NAME: Instacare Group, Inc. DATE OF NAME CHANGE: 20171120 D 1 primary_doc.xml X0708 D LIVE 0001723292 Cleo Labs, Inc 85 2nd Street Suite 710 San Francisco CA CALIFORNIA 94105 (415) 935-1009 DELAWARE Instacare Group, Inc. Corporation true 2016 Shannon Spanhake 85 2nd Street Suite 710 San Francisco CA CALIFORNIA 94105 Executive Officer Director Sarah Guo 85 2nd Street Suite 710 San Francisco CA CALIFORNIA 94105 Director Vanessa Larco 85 2nd Street Suite 710 San Francisco CA CALIFORNIA 94105 Director Other Technology Decline to Disclose 06b false 2018-12-21 false true true Series B Preferred Stock and the Common Stock issuable upon the conversion thereof. false 0 27500000 27381855 118145 false 13 0 0 0 false Cleo Labs, Inc /s/Shannon Spanhake Shannon Spanhake Chief Executive Officer 2019-04-04